bk-2C-B

bk-2C-B is a psychedelic substance of the phenethylamine class and a β-keto derivative of 2C-B. Richard Glennon and colleagues first reported it in the scientific literature in 2004, and it later appeared as a novel designer drug on European markets in 2013. While it did not generate significant excitement upon its appearance, it remained consistently available and was sampled by a relatively large number of users. The drug is administered orally.

Also known as: 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one

Classification

Chemical: Phenethylamine
Psychoactive: Psychedelic
Tag: Common
Tag: Hallucinogen
Tag: Research-Chemical
Tag: Substituted phenethylamine

Effects

Spontaneous Tactile Sensations
Stimulation
Nausea
Pupil Dilation
Mentalphysical Stimulation
Decreased Appetite
Emotion Enhancement
Thought Acceleration
Novelty Enhancement
Time Distortion
Analysis Enhancement
Personal Bias Suppression
Tactile Enhancement
Bodily Control Enhancement
Hallucinations
Drifting
Tracers
After Images

Routes of Administration

Oral

Dosage

Heavy: 1000 mg
Light: 80 – 150 mg
Common: 150 – 500 mg
Strong: 500 – 1000 mg
Threshold: 50-60 mg

Duration

Onset: 0.33-1.17 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu